|
Introduction The majority of pharmacist-run repeat prescribing medication review clinics have used the number of regular prescription items as the method of patient identification.1-3 Using such an indiscriminate method of identification can result in unnecessary consultations. It may be more appropriate to identify patients who are prescribed drugs with known potential for causing medication-related problems, eg, diuretics.2 Diuretics are known to be associated with adverse effects such as metabolic disturbances.4,5
Method Pharmacist-run medication review clinics were carried out in two general medical practices within the same primary care group. Repeat prescription of at least five items was used to identify patients in Clinic 1 and prescription for diuretics other than frusemide or bendrofluazide 2.5mg alone was used in Clinic 2.
|
Focal points
|
Results A total of 97 patients was seen in Clinic 1 and 50 in Clinic 2. The mean (SD) ages were 71.0 (11.0) and 69.7 (10.9) years respectively; 66.3 per cent and 78.2 per cent of patients were female. The age and sex distributions of the two clinics were not significantly different.
Table 1 provides a summary of the results from both clinics. For only six (6.2 per cent) and three (6.0 per cent) of Clinic 1 and 2 patients, respectively, were there no clinical interventions. Twenty-five (26 per cent) and 27 (54 per cent) patients in Clinics 1 and 2, respectively, required blood pressure monitoring and 32 (33 per cent) and 18 (36 per cent) required blood sampling to assess renal/hepatic/thyroid function, electrolytes, cholesterol or serum drug levels.
|
Discussion and conclusions The types of interventions generated from the medication reviews were similar in the two clinics. The numbers of patients for whom no clinical interventions were made were low and similar in the two clinics, suggesting that there were few unnecessary consultations.
Although the annual drug cost savings generated from Clinic 1 were greater, this was not statistically significant; this may be a type II error due to small sample size.
To demonstrate the true value of using the two methods of patient identification, further work to describe and compare the clinical consequences of non-intervention is required.
Better promotion of rational prescribing to GPs and more efficient management of repeat prescribing systems may have made the clinics unnecessary.
School of pharmacy, University of Bradford
| 1. Burtonwood AM, Hinchliffe AL, Tinkler GG. A prescription for quality: a role for the clinical pharmacist in general practice. Pharm J 1998;261:678-80. |
| 2. Sykes D, Westwood P, Gilleghan J. Development of a review programme for repeat prescription medicines. Pharm J 1996;256:458-60. |
| 3. Goldstein R, Hulme H, Willits J. Reviewing repeat prescribing: general practitioners and community pharmacists working together. Int J Pharm Prac 1998;6:60-6. |
| 4. Baglin A, Boulard J-C, Hanslik T, Prinseau J. Metabolic adverse reactions to diuretics - clinical relevance to elderly patients. Drug Safety 1995;12:161-67. |
| 5. Hyams DE. The elderly patient: a special case for diuretic therapy. Drugs 1986;31 Suppl 4;138-51. |